Clinical Trial Update: Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on maintenance therapy with Thalidomide-Dexamethasone after ThaDD in multiple myeloma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Università Politecnica delle Marche | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED